South Korea · Delayed Price · Currency is KRW GeneOne Life Science Statistics
Total Valuation
KRX:011000 has a market cap or net worth of KRW 106.99 billion. The enterprise value is 135.42 billion.
| Market Cap | 106.99B |
| Enterprise Value | 135.42B |
Important Dates
The next estimated earnings date is Thursday, May 28, 2026.
| Earnings Date | May 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:011000 has 90.67 million shares outstanding. The number of shares has increased by 6.09% in one year.
| Current Share Class | 90.67M |
| Shares Outstanding | 90.67M |
| Shares Change (YoY) | +6.09% |
| Shares Change (QoQ) | +6.98% |
| Owned by Insiders (%) | 6.78% |
| Owned by Institutions (%) | 4.22% |
| Float | 74.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.25 |
| PB Ratio | 2.09 |
| P/TBV Ratio | 2.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.98 |
| EV / Sales | 7.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.51 |
Financial Position
The company has a current ratio of 0.46, with a Debt / Equity ratio of 0.67.
| Current Ratio | 0.46 |
| Quick Ratio | 0.16 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.15 |
| Interest Coverage | -7.93 |
Financial Efficiency
Return on equity (ROE) is -71.19% and return on invested capital (ROIC) is -24.31%.
| Return on Equity (ROE) | -71.19% |
| Return on Assets (ROA) | -16.93% |
| Return on Invested Capital (ROIC) | -24.31% |
| Return on Capital Employed (ROCE) | -48.23% |
| Weighted Average Cost of Capital (WACC) | 7.98% |
| Revenue Per Employee | 417.61M |
| Profits Per Employee | -1.11B |
| Employee Count | 41 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 2.05 |
Taxes
| Income Tax | -109.21M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.87% in the last 52 weeks. The beta is 0.51, so KRX:011000's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -65.87% |
| 50-Day Moving Average | 1,006.70 |
| 200-Day Moving Average | 1,763.69 |
| Relative Strength Index (RSI) | 52.22 |
| Average Volume (20 Days) | 12,831,968 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:011000 had revenue of KRW 17.12 billion and -45.40 billion in losses. Loss per share was -536.46.
| Revenue | 17.12B |
| Gross Profit | -13.41B |
| Operating Income | -37.31B |
| Pretax Income | -45.50B |
| Net Income | -45.40B |
| EBITDA | -23.49B |
| EBIT | -37.31B |
| Loss Per Share | -536.46 |
Balance Sheet
The company has 5.72 billion in cash and 34.15 billion in debt, with a net cash position of -28.43 billion or -313.52 per share.
| Cash & Cash Equivalents | 5.72B |
| Total Debt | 34.15B |
| Net Cash | -28.43B |
| Net Cash Per Share | -313.52 |
| Equity (Book Value) | 51.15B |
| Book Value Per Share | 579.84 |
| Working Capital | -29.25B |
Cash Flow
In the last 12 months, operating cash flow was -15.90 billion and capital expenditures -23.82 million, giving a free cash flow of -15.92 billion.
| Operating Cash Flow | -15.90B |
| Capital Expenditures | -23.82M |
| Depreciation & Amortization | 13.83B |
| Net Borrowing | 12.50B |
| Free Cash Flow | -15.92B |
| FCF Per Share | -175.58 |
Margins
Gross margin is -78.35%, with operating and profit margins of -217.93% and -265.13%.
| Gross Margin | -78.35% |
| Operating Margin | -217.93% |
| Pretax Margin | -265.77% |
| Profit Margin | -265.13% |
| EBITDA Margin | -137.18% |
| EBIT Margin | -217.93% |
| FCF Margin | n/a |
Dividends & Yields
KRX:011000 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.09% |
| Shareholder Yield | -6.09% |
| Earnings Yield | -42.43% |
| FCF Yield | -14.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 3, 2021. It was a forward split with a ratio of 1.5.
| Last Split Date | Dec 3, 2021 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
KRX:011000 has an Altman Z-Score of -3.14 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.14 |
| Piotroski F-Score | 1 |